Same Drug Class

Methotrexate vs Nivolumab

Methotrexate vs Nivolumab: Overview

This comparison examines the pharmacological differences between Methotrexate and Nivolumab.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5.

Molecular Weight: Methotrexate — 454.4400 g/mol.

Type: Methotrexate — Small molecule; Nivolumab — Antibody.